4-METHOXYPYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid compound with methanesulfonic acid (1:1), 98%, 5g

TERT-BUTYL 2-(HYDROXYMETHYL)-5-OXOPYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg

1-Octanethiol, 99.0%, 100g

5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Zirconium foil 99.8% 0.25 x 150 x 150 mm 1 pc

2-(cis-4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid, 99.0%, 1g

Methyl 2-chloro-5-fluoroisonicotinate, 95.0%, 1g

3-(tert-Butyl)-1-(2-methoxyphenyl)-1H-pyrazol-5-amine, 95.0%, 2.5g

4-(6-Chloro-2-methylpyrimidin-4-yl)morpholine, 95.0%, 1g

7-(Trifluoromethyl)isoquinoline, 98%, 100mg

(E)-3-(2-Methylpyridin-4-yl)acrylic acid, 98%, 500mg

4-Fluoroindole, 98.0%, 100g